Bankrupt DNA testing company 23andMe to be acquired by Regeneron for $256 million | – The Times of India
Regeneron Pharmaceuticals has announced it will acquire 23andMe, the once high-flying consumer DNA testing company, for $256 million through a bankruptcy auction. The deal comes after 23andMe filed for Chapter 11 bankruptcy protection in March amid plummeting demand for its ancestry kits and fallout from a 2023 data breach. Regeneron, a major player in biotech…
